Axsome Thera
(AXSM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 202,360 | 190,682 | 197,313 | 219,966 | 43,642 |
| TOTAL | $203,272 | $190,819 | $197,623 | $220,379 | $44,236 |
| Non-Current Assets | |||||
| PPE Net | 40 | 30 | 35 | 31 | 35 |
| Other Non-Current Assets | 317 | 140 | 144 | 140 | 169 |
| TOTAL | $357 | $170 | $178 | $171 | $204 |
| Total Assets | $203,629 | $190,990 | $197,801 | $220,550 | $44,440 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 649 |
| Accounts payable and accrued liabilities | 11,315 | 9,363 | 12,192 | 10,943 | 9,447 |
| Accrued Expenses | 9,026 | 7,092 | 9,340 | 10,949 | 8,413 |
| TOTAL | $20,342 | $23,002 | $26,100 | $24,495 | $18,509 |
| Non-Current Liabilities | |||||
| Long Term Debt | 48,026 | 13,744 | 15,544 | 17,333 | 19,108 |
| TOTAL | $48,026 | $13,744 | $15,544 | $17,333 | $19,108 |
| Total Liabilities | $68,368 | $36,746 | $41,644 | $41,827 | $37,617 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,344 | 37,284 | 37,076 | 37,075 | 34,509 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -249,631 | -226,707 | -208,380 | -175,896 | -151,089 |
| TOTAL | $135,262 | $154,243 | $156,157 | $178,722 | $6,823 |
| Total Liabilities And Equity | $203,630 | $190,990 | $197,801 | $220,550 | $44,440 |